首页 | 本学科首页   官方微博 | 高级检索  
     


Purification and characterization of human platelet von Willebrand factor
Authors:Sybil B.  Williams   Laurie P.  McKeown   Henry  Krutzsch  Kristin  Hansmann   Harvey R.  Gralnick
Affiliation:Hematology Service, Clinical Center, National Institutes of Health, Bethesda, Maryland, U.S.A.;Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, U.S.A.
Abstract:
Summary. Platelet von Willebrand factor (vWf) was purified from human platelet concentrates. The multimeric structure of the purified platelet vWf was similar to that observed in the initial platelet lysate, and, like the platelet lysate, the purified platelet vWf contained higher molecular weight multimers than plasma vWf. The apparent molecular weight of the reduced platelet vWf subunit was similar to the plasma vWf subunit. The N-terminal amino acid of the purified platelet and plasma vWf was blocked. In concentration dependent binding to botrocetin- or ristocetin-stimulated platelets, 125I-plasma vWf bound with a higher affinity than platelet. The ristocetin cofactor activity per mg of purified plasma vWf was 5-fold greater than the platelet vWf activity. Platelet and plasma vWf bound to collagen with similar affinities; however, platelet vWf bound to thrombin-stimulated platelets and to heparin with a higher affinity than plasma vWf. The differences in the binding affinity(s) of plasma and platelet vWf to platelet GPIb and GPIIb/IIIa and extracellular matrix proteins may reflect different roles for plasma and platelet vWf in the initial stages of haemostasis and thrombosis.
Keywords:platelet adhesion    thrombosis    haemostasis    platelet    von Willebrand factor
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号